An eighth case of monkeypox in northern California has been detected in an individual who recently returned from Europe, it was revealed on Tuesday afternoon as the virus continued to spread around the world.
Health officials said the unnamed patient came to a Sacramento County clinic with a city of 500,000 on May 21, just one day after returning from abroad.
They are now isolating themselves at home and are being tracked by contacts, including people who shared the same flight, although they said in a briefing that the risk of other people in the state becoming infected was “extremely low”.
This is the third suspicious case to be detected this week, after Washington announced its first case and Florida said it was investigating a second one on Monday. There are now seven suspected cases in the U.S. in six east and west coast states, and one confirmed infection in Massachusetts.
None of the patients have been named, but the Centers for Disease Control and Prevention (CDC) revealed Monday that they were all men and had traveled internationally for the past month.
Globally, the total has risen to more than 200 confirmed infections in at least 20 nations, most in Europe, with at least 100 more being investigated. European health officials have warned that the virus could become endemic on the continent, as it is in West Africa, if it spread to local wildlife.
Cases are being disproportionately detected between gay and bisexual men, and experts suggest that the outbreak is related to sex in two radishes in Spain and Belgium.
Concern has also been raised that the disease has evolved to become more infectious after tests revealed that it had acquired an additional 50 mutations. But the World Health Organization (WHO) said yesterday that there were no indications that the virus had become more transmissible.
The suspicious case of California makes the Golden State the sixth with at least one potential case within its borders and brings the total to eight presumptive cases.
The map above shows the number of confirmed and suspected cases worldwide, including the US. Currently, the outbreak is mainly concentrated in Europe
Monkeypox, first discovered in laboratory monkeys in the late 1950s, is usually mild, but can cause serious illness in some cases. It can kill up to 10 percent of people it infects. But this outbreak is the lightest strain of the West African virus, which has a mortality rate of around one in 100 cases.
The disease has an incubation period of up to 21 days, which means that it can take three weeks for symptoms to appear. Patients then become infected as long as they have warning signs of the disease.
Symptoms include fever, headache, muscle aches, back pain, swollen lymph nodes, chills, and exhaustion. A rash can also develop, often starting on the face, which then spreads to other parts of the body, including the genitals. The rash may look like chickenpox or syphilis, and crusts may form and then fall off.
Modern test for the smallpox vaccine in the United States and Europe
Moderna has revealed that it is testing a possible monkeypox vaccine in the United States and Europe.
Leading vaccine maker Covid said it was taking action amid concerns by the World Health Organization about the outbreak.
His vaccine is currently at the “preclinical level” and it is unclear what technology he will use.
Smallpox is commonly found in West Africa, where it spreads to humans from animals, including squirrels.
But a recent wave of cases has seen it emerge in countries where it is not normally found.
European health officials warn that the virus could become endemic on the continent if it spreads to animals there.
Revealing the suspected case this afternoon, Sacramento Public Health Officer Dr. Olivia Kaisye said the risk to people in the area was still “extremely low.”
They said in a briefing: “This case seems to be related to a recent trip to Europe.
‘Public Health is working with [the Department of Health] to track contacts, and the risk to the general public is extremely low. “
Last night, Washington officials said a man who had recently returned from abroad had tested positive for the virus family, which includes smallpox.
The individual, from King County, Seattle’s home, is now isolating himself at home and awaiting the results of CDC confirmation tests.
Health officials say it is a “possibility” that the monkey’s smallpox has spread to other people in the state, although they have so far found “no evidence” of subsequent transmission.
Local health chief Dr Jeff Duchin said: “The risk to the public is low, but it is important for doctors and the public to be aware of the symptoms and risk factors for monkeypox.”
Florida also revealed a second suspicious case on Monday in another individual in Broward County, bordering Miami. It was unclear if this was related to the first Sunday reported in the same county.
So far, one case has been confirmed in Massachusetts. Health officials are also investigating two cases in Florida and Utah, and one case each in New York City, Washington, and now California.
More than 200 people, mostly health workers, are being monitored for monkeypox infection in Massachusetts, CDC officials said yesterday.
But the risk of people catching the virus is low, they added, because it usually requires sustained skin-to-skin contact.
Health officials were monitoring six people for a possible infection after sitting in three rows of a case on a seven-hour flight from Nigeria to the UK. There have been no subsequent positive reports.
Smallpox from the monkey is usually transmitted through infectious skin lesions, but can also be transmitted through air droplets.
At a CDC briefing yesterday, Dr. John Brooks, the agency’s medical epidemiologist, said many of the patients in the outbreak had genital injuries.
He added that in some cases they are confused with a “very bad” case of herpes.
The CDC said yesterday it had opened vaccination stocks to treat “high-risk” people exposed to the virus.
More than 1,000 doses of Jynneous, a vaccine that can treat both smallpox and smallpox, are now being given to high-risk people in the United States.
People who receive the vaccine may receive it for the first time shortly after a possible exposure to boost their immunity levels. They should also receive a second shot in four weeks.
The general manager of Bavarian Nordic, which makes the vaccine, revealed on Tuesday that they had been inundated with calls.
He told CNBC: “We’re increasing production as we talk and hope we can deliver doses. We’ve already delivered some doses to some European countries, and we’re doing more this week. ‘
People infected with monkeypox often have severe rashes, skin lesions, and flu-like symptoms. The virus kills about one in ten people it infects, although it is believed that the current strain that makes its way around the world has a mortality rate of one percent.
Concern has been raised that the monkey’s smallpox has evolved “much more” than expected, as the virus seen only in West Africa continues to ravage the world.
Portuguese virologists, who are in charge of conducting studies similar to Covid to track the evolution of the virus, say that the current strain is very similar to that which arose in Britain four years ago.
But samples taken from a handful of patients affected by the new outbreak suggest that the virus has picked up an additional 50 mutations.
The researchers wrote that this was “much more than would be expected given the estimated orthopoxvirus replacement rate.” They also warned that an “evolutionary leap”, as with the Covid Omicron strain, could have created a “hypermute virus”.
Meanwhile, the Danish smallpox vaccine maker, which is also effective against smallpox, warned last year that outbreaks were becoming more frequent. He said it could be due to the “genetic evolution” of the virus.
But experts are still analyzing the genome of the monkeypox and the WHO said yesterday that there were no indications that it had mutated. The current strain circulating worldwide is much lighter than other viruses.